MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1-Reference-Cited by-同舟云学术

MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1

Published:2023-11-15 Issue:1 Volume:51 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Choi Sujin¹,An Hyun-Ju¹,Yeo Hyun¹,Sung Min-Ji¹,Oh Jisu²,Lee Kwanbum³,Lee Seung³,Kim Seung³,Kim Junhan¹,Kim Isaac³,Lee Soonchul¹

Affiliation:

1. Department of Orthopedic Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi 13488, Republic of Korea

2. Division of Hemato‑Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi 16995, Republic of Korea

3. Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi 13488, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference35 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci USA,2001

3. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

4. The roles of microRNAs in breast cancer;Takahashi;Cancers (Basel),2015

5. MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance and applications in human triple-negative breast cancer;Ding;Cells,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review;Medical Oncology;2024-08-09

2. Injectable nano-in situ-thermosensitive-hydrogels based on halofuginone and silver for postoperative treatment against triple-negative breast cancer;International Journal of Pharmaceutics;2024-08

3. Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation;Cells;2024-05-11